Subscribe to Newsletter

Content by Mark Hillen:

Business & Profession Other

The Road to Hell Is Paved with Good Intentions

| Mark Hillen

Maurice Saatchi wants new legislation to free British doctors from fear of litigation in the pursuit of innovation. Others view it as a charlatan’s charter

Business & Profession Business and Innovation

The Innovation Awards 2014

| Mark Hillen

Showcasing the greatest ophthalmic advances of the year

Business & Profession Business and Innovation

The Top 5 Lessons from Ophthalmology Futures 2014

| Mark Hillen

The world’s top clinicians and captains of industry came together in London last month to discuss the future of ophthalmology. Here’s what we learned

Subspecialties Retina

Benchmarking VMA/VMT

| Mark Hillen

What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?

Subspecialties Retina

A Glut of Glucose? Gibberish!

| Mark Hillen

Statins may interfere with glucose metabolism, and their use might be damaging the diabetic eye. Or perhaps not...

Subspecialties Retina

VIIP: A Space Odyssey

| Mark Hillen

Many astronauts develop eye problems in space. NASA wants to know why, so they’ve established the Vision Impairment and Intracranial Pressure (VIIP) program.

Subspecialties Retina

Choroid Cartography

| Mark Hillen

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Subspecialties Cataract

IOL Clinical Trials

| Mark Hillen

One of the most commonly performed surgical procedures in the world is cataract surgery

Business & Profession Professional Development

Being Engaged

| Mark Hillen

The Ophthalmologist is one year old. We promised to tell you ophthalmology’s most engaging stories, and we’ve traveled the world to do so.

Subspecialties Retina

A Retinoid a Day Keeps The Blindness Away

| Mark Hillen

Oral replacement therapy of the retinoid intermediate that fails to form in some types of Leber congenital amaurosis shows significant promise in an early-phase clinical trial

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer element

This new disclaimer element is now part of all brands. It is editable on the start page and will be shown on all pages

Once confirmed we store a cookie to not show the disclaimer again.